Maximum Stremgth Pain Relief
Product Images NDC 50804-775

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Maximum Stremgth Pain Relief (NDC 50804-775). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Good Sense, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Back)

Image Description (Back)
This is a description of a product that appears to be a topical cream or ointment. The text provides some information about the purpose of the product, but it is not clear what it is intended to treat. The directions for use indicate that it should be applied to affected areas, but there is no information about what those might be. There is a warning to stop using the product if the condition worsens or persists for more than seven days, and to seek medical attention if swallowed or if it comes into contact with the eyes. The product should be kept out of reach of children. There is also information about the manufacturer and distributor of the product. However, the text is difficult to read and some parts are not available.*
FDA Label Image

Image Description (Front)

Image Description (Front)
This is a description of a pain relief cream that is fragrance-free. The cream contains 2% Lidocaine Hydrochloride, which is a topical anesthetic for temporary relief of pain. It is compared to Aspercreme OdorFree, which also contains 4.5% Lidocaine. However, this cream is fragrance-free.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.